Clinical trial

Mild Cognitive Impairment, Use of qEEG as a Prognostic Marker

NCT03659643

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2018-01-01

PhaseN/A

Study timeline

Study start (actual)2018-01-01Date precision: day

Registry last updated2018-09-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Cognitive Impairmentunresolved

Interventions

EEG with SPR analysisDIAGNOSTIC_TEST

Sponsors & collaborators

Jon Snaedallead sponsor

Ullevaal University Hospitalcollaborator

Karolinska University Hospitalcollaborator

Copenhagen University Hospital, Rigshospitaletcollaborator

Zealand University Hospitalcollaborator

Haukeland University Hospitalcollaborator

Kavli Research Foundation, Bergen Norwaycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03659643 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.